Literature DB >> 21566422

All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome.

Debanjali Mitra1, Keith L Davis, Robert W Baran.   

Abstract

OBJECTIVE: Chronic idiopathic constipation and irritable bowel syndrome (IBS) are common gastrointestinal conditions with potentially significant burden on managed care systems. Our objective was to examine all-cause resource utilization and charges associated with constipation alone (C-only) and with IBS with comorbid constipation (IBS+C).
METHODS: Administrative claims from a US health plan between January 1, 2003 and December 31, 2005 were analyzed. Patients with C-only (n = 48 585) and IBS+C (n = 10 952) were identified using International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes. Outcomes were compared with demographically matched controls and with a benchmark group of patients with migraine (N = 48 759). An index date was defined as the date 3 months prior to first observed diagnosis of the condition of interest. Outcomes were evaluated over a 12-month period before and after the index date.
RESULTS: The pre-to-post increase in total charges for subjects with C-only was substantially higher than that for the comparison group ($8837 vs $1717; P < 0.001) or the migraine group ($8837 vs $ 4804; P < 0.001). Subjects with IBS+C also had a greater pre-to-post increase in total charges than did comparison group members ($6192 vs $1319; P < 0.001) and subjects with migraine ($6192 vs $4804; P = 0.0120).
CONCLUSIONS: Both C-only and IBS+C impose substantial economic burden on third-party payers.

Entities:  

Mesh:

Year:  2011        PMID: 21566422     DOI: 10.3810/pgm.2011.05.2290

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  8 in total

1.  TummyTrials: A Feasibility Study of Using Self-Experimentation to Detect Individualized Food Triggers.

Authors:  Ravi Karkar; Jessica Schroeder; Daniel A Epstein; Laura R Pina; Jeffrey Scofield; James Fogarty; Julie A Kientz; Sean A Munson; Roger Vilardaga; Jasmine Zia
Journal:  Proc SIGCHI Conf Hum Factor Comput Syst       Date:  2017-05-02

2.  Boundary Negotiating Artifacts in Personal Informatics: Patient-Provider Collaboration with Patient-Generated Data.

Authors:  Chia-Fang Chung; Kristin Dew; Allison Cole; Jasmine Zia; James Fogarty; Julie A Kientz; Sean A Munson
Journal:  CSCW Conf Comput Support Coop Work       Date:  2016-02-27

Review 3.  Irritable bowel syndrome: a concise review of current treatment concepts.

Authors:  Geoffrey C Wall; Ginelle A Bryant; Michelle M Bottenberg; Erik D Maki; Andrew R Miesner
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  A framework for self-experimentation in personalized health.

Authors:  Ravi Karkar; Jasmine Zia; Roger Vilardaga; Sonali R Mishra; James Fogarty; Sean A Munson; Julie A Kientz
Journal:  J Am Med Inform Assoc       Date:  2015-12-07       Impact factor: 4.497

5.  A Patient-Centered Proposal for Bayesian Analysis of Self-Experiments for Health.

Authors:  Jessica Schroeder; Ravi Karkar; James Fogarty; Julie A Kientz; Sean A Munson; Matthew Kay
Journal:  J Healthc Inform Res       Date:  2018-09-25

6.  Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome.

Authors:  Emily B Hollister; Kevin C Cain; Robert J Shulman; Monica E Jarrett; Robert L Burr; Cynthia Ko; Jasmine Zia; Claire J Han; Margaret M Heitkemper
Journal:  J Clin Gastroenterol       Date:  2020-02       Impact factor: 3.174

7.  Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision-analytic model.

Authors:  Jordana K Schmier; Paige E Miller; Jessica A Levine; Vanessa Perez; Kevin C Maki; Tia M Rains; Latha Devareddy; Lisa M Sanders; Dominik D Alexander
Journal:  BMC Public Health       Date:  2014-04-17       Impact factor: 3.295

8.  Variation in Care for Patients with Irritable Bowel Syndrome in the United States.

Authors:  Brian E Lacy; Haridarshan Patel; Annie Guérin; Katherine Dea; Justin L Scopel; Reza Alaghband; Eric Qiong Wu; Reema Mody
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.